CN Patent

CN1980917B — 作为选择性雄激素受体调节剂（sarms）的新的吲哚衍生物

Assigned to Janssen Pharmaceutica NV · Expires 2014-02-12 · 12y expired

What this patent protects

本发明涉及新的吲哚衍生物、含它们的药用组合物以及它们在治疗由雄激素受体介导的疾病和病症中的应用。

USPTO Abstract

本发明涉及新的吲哚衍生物、含它们的药用组合物以及它们在治疗由雄激素受体介导的疾病和病症中的应用。

Drugs covered by this patent

elacestrant-hydrochloride (ELACESTRANT HYDROCHLORIDE)

Patent Metadata

Patent number: CN1980917B
Jurisdiction: CN
Classification: —
Expires: 2014-02-12
Drug substance claim: No
Drug product claim: No
Assignee: Janssen Pharmaceutica NV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.